Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Aug 18, 2021 4:01pm
102 Views
Post# 33724968

RE:RE:RE:RE:Unfortunately

RE:RE:RE:RE:Unfortunately
What does your question and theories have to do with my comment about you telling readers that there is nothing here worth anyone's time... but yet you are still around?
 
To answer your question of what's in store next...I don't know but I will wait to see what they do with the PK data.
 
Here is what I do know however;
 
They had $30M CAD in cash at the end of June with more to come as only $10.7M CAD out of $22M USD had been rec'd by the end of Q2
 
They will have access to $72.5M USD in the coming weeks/months
 
Net loss from continuing operations was $12.6M CAD in Q2 (4.2M/month) I would think that this will drop once Ryplazim deal is finalized.
 
Also gone are expenses related to the plasma business which impacted Q2 pretty hard at $30M with ;  "Loss from discontinued operations" $21.9M CAD!
 
Why isn't Thompson stepping in to bridge the loan? Probably because it is not needed at this point. Could it be one of the options envisioned if needed...perhaps, who knows!
 
Finally, the pumpers are no worse than all the spammers posting baseless predictions and garbage. 
 
GoBBs wrote:
Aldo, please enlighten me about the wonderful prospects of LMNL ...I've been here for many years too and all I see is a massive failure of fiduciary duty, no pipeline and TV owns them and their IP. To pump this company from the likes of newcamopando is discgraceful.


<< Previous
Bullboard Posts
Next >>